Literature DB >> 19732742

Role of MGAT2 and DGAT1 in the release of gut peptides after triglyceride ingestion.

Mayumi Okawa1, Kenji Fujii, Katsuya Ohbuchi, Mayumi Okumoto, Katsumi Aragane, Hiromu Sato, Yoshitaka Tamai, Toru Seo, Yoshiki Itoh, Ryo Yoshimoto.   

Abstract

Triglyceride ingestion releases gut peptides from enteroendocrine cells located in the intestinal epithelia and provides feedback regulations of gastrointestinal function. The precise mechanisms sensing lipids in the intestinal wall, however, are not well characterized. In the current study, we investigated the release of gut peptides following oral triglyceride loading in mice deficient for monoacylglycerol acyltransferase 2 (MGAT2KO) and diacylglycerol acyltransferase 1 (DGAT1KO), enzymes that sequentially re-synthesize triglyceride to secrete as chylomicron at the small intestine. In wild-type (Wt) mice, oral triglyceride loading resulted in hypertriglycemia. In addition, plasma glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1) and peptide YY (PYY) were significantly increased 30 min after triglyceride loading, before decaying in 2h. In MGAT2KO and DGAT1KO mice, oral triglyceride loading did not result in hypertriglycemia and the increase in GIP was significantly suppressed in both KO mouse strains. In contrast, the increases in plasma GLP-1 and PYY in both KO mouse strains were comparable to Wt mice 30 min after triglyceride loading, however, they remained elevated in DGAT1KO mice even 2h after triglyceride loading. In parallel to the changes in GLP-1 and PYY, gastric emptying was delayed after oral triglyceride loading in MGAT2KO mice comparably to Wt type mice and was further delayed in DGAT1KO mice. STC-1 and GLUTag, GLP-1-producing intestinal endocrine L-cell lines, displayed a significant level of DGAT1 activity but not MGAT activity. These findings suggest that synthesis and/or secretion of triglyceride-rich lipoproteins play an important role in the release of GIP. Moreover, DGAT1 may directly regulate the release of GLP-1 and PYY in L-cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19732742     DOI: 10.1016/j.bbrc.2009.08.167

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  27 in total

Review 1.  Mammalian triacylglycerol metabolism: synthesis, lipolysis, and signaling.

Authors:  Rosalind A Coleman; Douglas G Mashek
Journal:  Chem Rev       Date:  2011-06-01       Impact factor: 60.622

2.  Deficiency of MGAT2 increases energy expenditure without high-fat feeding and protects genetically obese mice from excessive weight gain.

Authors:  David W Nelson; Yu Gao; Nicole M Spencer; Taylor Banh; Chi-Liang Eric Yen
Journal:  J Lipid Res       Date:  2011-07-06       Impact factor: 5.922

3.  Diacylglycerol acyltransferase-1 inhibition enhances intestinal fatty acid oxidation and reduces energy intake in rats.

Authors:  Gudrun Schober; Myrtha Arnold; Susan Birtles; Linda K Buckett; Gustavo Pacheco-López; Andrew V Turnbull; Wolfgang Langhans; Abdelhak Mansouri
Journal:  J Lipid Res       Date:  2013-02-28       Impact factor: 5.922

4.  MGAT2 deficiency and vertical sleeve gastrectomy have independent metabolic effects in the mouse.

Authors:  Joram D Mul; Denovan P Begg; April M Haller; Josh W Pressler; Joyce Sorrell; Stephen C Woods; Robert V Farese; Randy J Seeley; Darleen A Sandoval
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-10-14       Impact factor: 4.310

Review 5.  Obesity medications in development.

Authors:  Candida J Rebello; Frank L Greenway
Journal:  Expert Opin Investig Drugs       Date:  2019-12-19       Impact factor: 6.206

Review 6.  Nutrition and L and K-enteroendocrine cells.

Authors:  Ruth Gutierrez-Aguilar; Stephen C Woods
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2011-02       Impact factor: 3.243

Review 7.  Intestinal triacylglycerol synthesis in fat absorption and systemic energy metabolism.

Authors:  Chi-Liang Eric Yen; David W Nelson; Mei-I Yen
Journal:  J Lipid Res       Date:  2014-09-17       Impact factor: 5.922

8.  Development of novel benzomorpholine class of diacylglycerol acyltransferase I inhibitors.

Authors:  Gang Zhou; Nicolas Zorn; Pauline Ting; Robert Aslanian; Mingxiang Lin; John Cook; Jean Lachowicz; Albert Lin; Michelle Smith; Joyce Hwa; Margaret van Heek; Scott Walker
Journal:  ACS Med Chem Lett       Date:  2014-03-01       Impact factor: 4.345

9.  Targeting Acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) with small molecule inhibitors for the treatment of metabolic diseases.

Authors:  Jingsong Cao; Yingjiang Zhou; Haibing Peng; Xinyi Huang; Shannon Stahler; Vipin Suri; Ariful Qadri; Tiffany Gareski; Juli Jones; Seung Hahm; Mylene Perreault; John McKew; Mengxiao Shi; Xin Xu; James F Tobin; Ruth E Gimeno
Journal:  J Biol Chem       Date:  2011-10-11       Impact factor: 5.157

10.  High fat diet induces microbiota-dependent silencing of enteroendocrine cells.

Authors:  Lihua Ye; Olaf Mueller; Jennifer Bagwell; Michel Bagnat; Rodger A Liddle; John F Rawls
Journal:  Elife       Date:  2019-12-03       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.